Instil Bio News

Instil Bio Analyst Ratings

BenzingaApr 12 09:22 ET

Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Instil Bio (TIL) and Regeneron (REGN)

TipRanksApr 12 05:20 ET

Instil Bio Analyst Ratings

BenzingaMar 25 06:06 ET

Analysts' Top Healthcare Picks: Instil Bio (TIL), Evolus (EOLS)

TipRanksJan 22 15:30 ET

Instil Bio Analyst Ratings

BenzingaJan 19 14:12 ET

Instil Bio Analyst Ratings

BenzingaJan 17 14:32 ET

HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $2 Price Target

BenzingaNov 14, 2023 06:27 ET

Instil Bio Analyst Ratings

BenzingaNov 14, 2023 06:26 ET

Truist Financial Remains a Hold on Instil Bio (TIL)

TipRanksSep 6, 2023 22:25 ET

HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $2 Price Target

BenzingaAug 17, 2023 06:33 ET

Instil Bio Analyst Ratings

BenzingaAug 17, 2023 06:33 ET

Analysts Are Bullish on Top Healthcare Stocks: Relay Therapeutics (RLAY), Instil Bio (TIL)

TipRanksAug 17, 2023 06:30 ET

Instil Bio (TIL) Gets a Buy From H.C. Wainwright

TipRanksJun 29, 2023 06:15 ET

HC Wainwright & Co. Initiates Coverage On Instil Bio With Buy Rating, Announces Price Target of $2

BenzingaJun 29, 2023 06:10 ET

Analysts Offer Insights on Healthcare Companies: Instil Bio (TIL) and Regulus (RGLS)

TipRanksMay 15, 2023 08:20 ET

Truist Securities Reinstates Hold on Instil Bio, Maintains $6 Price Target

BenzingaApr 5, 2023 08:54 ET

Robert W. Baird Sticks to Its Buy Rating for Instil Bio (TIL)

TipRanksFeb 2, 2023 22:10 ET

Instil Bio (TIL) Gets a Buy From Robert W. Baird

TipRanksJan 12, 2023 00:30 ET

What 4 Analyst Ratings Have To Say About Instil Bio

Benzinga Real-time NewsDec 12, 2022 15:02 ET

Morgan Stanley Adjusts Instil Bio's Price Target to $2 From $6, Keeps Equalweight Rating

MT NewswiresDec 12, 2022 11:15 ET